Cargando…
A durable response to programmed cell death 1 blockade in a multidrug-resistant recurrent ovarian cancer patient with HLA-B44 supertype: A case report
Relapsed/refractory ovarian cancer, especially platinum resistance recurrence, remains a major therapeutic challenge. Here, we present the case of a patient with recurrent ovarian clear cell carcinoma (OCCC) who failed to respond to multiline chemotherapy and target therapy but achieved an immune co...
Autores principales: | Luo, Xukai, Sun, Yating, Li, Jiajia, Jiang, Qidi, Yuan, Lei, Li, Ting, Chen, Mo, Yao, Liangqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582938/ https://www.ncbi.nlm.nih.gov/pubmed/36275748 http://dx.doi.org/10.3389/fimmu.2022.951422 |
Ejemplares similares
-
Classification of Human Leukocyte Antigen (HLA) Supertypes
por: Wang, Mingjun, et al.
Publicado: (2014) -
HLA class I supertypes: a revised and updated classification
por: Sidney, John, et al.
Publicado: (2008) -
Cytoreductive surgery is feasible in patients with limited regional platinum-resistant recurrent ovarian cancer
por: Zou, Ruoyao, et al.
Publicado: (2023) -
A Naturally Selected Dimorphism within the HLA-B44 Supertype Alters Class I Structure, Peptide Repertoire, and T Cell Recognition
por: Macdonald, Whitney A., et al.
Publicado: (2003) -
A HLA-DRB supertype chart with potential overlapping peptide binding function
por: Mohanapriya, Arumugam, et al.
Publicado: (2010)